Ranolazine as a Cardioplegia Additive Improves Recovery of Diastolic Function in Isolated Rat Hearts
- 15 September 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (11_suppl_1) , S16-21
Abstract
Background— Ranolazine (Ran), an antianginal agent, inhibits late Na+ current. The purpose of this study was to determine whether there was an added benefit of adding Ran to cardioplegia (CP) in a model of global ischemia/reperfusion. Methods and Results— Isolated rat hearts were Langendorff-perfused and exposed to 40-minute normothermic, cardioplegic global ischemia and 30 minutes of reperfusion. Before ischemia and during reperfusion, hearts were treated with no drug (control) or with the late Na+ current inhibitors Ran (5 μmol/L) or tetrodotoxin (1 μmol/L). Ischemic cardioplegic arrest led to an increase of left ventricular end-diastolic pressure (LVEDP) by ≥20 mm Hg (ie, cardiac contracture). Ten out of 11 hearts treated with CP alone developed contracture, whereas 6 out of 11 hearts treated with CP plus Ran developed contracture. Ran added to CP reduced LVEDP at the end of ischemia from 41±5 mm Hg in CP alone to 26±3 mm Hg in CP plus Ran (P=0.024). Area under the curve for LVEDP during the entire isc...Keywords
This publication has 19 references indexed in Scilit:
- Ranolazine as an Adjunct to Cardioplegia: A Potential New Therapeutic ApplicationJournal of Cardiovascular Pharmacology and Therapeutics, 2009
- A Comparison between Ranolazine and CVT-4325, a Novel Inhibitor of Fatty Acid Oxidation, on Cardiac Metabolism and Left Ventricular Function in Rat Isolated Perfused Heart during Ischemia and ReperfusionThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat heartsJournal of Molecular and Cellular Cardiology, 2006
- Blocking Late Sodium Current Reduces Hydrogen Peroxide-Induced Arrhythmogenic Activity and Contractile DysfunctionThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Ranolazine: Ion‐channel‐blocking actions and in vivo electrophysiological effectsBritish Journal of Pharmacology, 2004
- Haemodynamic and electrocardiographic consequences of severe nicorandil toxicityEmergency Medicine Journal, 2003
- Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trialThe Lancet, 2002
- Insulin cardioplegia for elective coronary bypass surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Effect of glutamate-aspartate reperfusion on postischemic neonatal myocardiumThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principleCardiovascular Research, 1993